✦ LIBER ✦

Macrophage Activation Syndrome as a Severe Manifestation of Adult's Still's Disease. Hemophagocytic Cells in Ascites

✍ Scribed by Egües Dubuc, César; Uriarte Ecenarro, Miren; Errazquin Aguirre, Nerea; Belzunegui Otano, Joaquín

Book ID: 126704864
Publisher: Elsevier Science
Year: 2014
Tongue: Spanish
Weight: 172 KB
Volume: 10
Category: Article
ISSN: 2173-5743
DOI: 10.1016/j.reumae.2014.04.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reactive macrophage activation syndrome

Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease

✍ Banse, Christopher; Vittecoq, Olivier; Benhamou, Ygal; Gauthier-Prieur, Maud; Le 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 330 KB

Serum Calprotectin as a Marker for Disea

Serum Calprotectin as a Marker for Disease Activity and Severity in Adult-onset Still's Disease

✍ Jung, Sang Youn (author);Park, Yong Beom (author);Ha, You Jung (author);Lee, Kwa 📂 Article 📅 2010 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 298 KB

Serum Calprotectin as a Marker for Disea

Serum Calprotectin as a Marker for Disease Activity and Severity in Adult-onset Still's Disease

✍ Jung, Sang Youn (author);Park, Yong Beom (author);Ha, You Jung (author);Lee, Kwa 📂 Article 📅 2010 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 298 KB

Adult-onset Still’s disease with macroph

Adult-onset Still’s disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept

✍ Keisuke Maeshima; Koji Ishii; Mikako Iwakura; Misuzu Akamine; Hajime Hamasaki; I 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 282 KB

Benefit and a possible risk of tocilizum

Benefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndrome

✍ Masafumi Kobayashi; Yuko Takahashi; Hiroyuki Yamashita; Hiroshi Kaneko; Akio Mim 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 201 KB

Benefit and a possible risk of tocilizum

Benefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndrome

✍ Kobayashi, Masafumi; Takahashi, Yuko; Yamashita, Hiroyuki; Kaneko, Hiroshi; Mimo 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 224 KB